Intrinsically Biocompatible Polymer Systems
Biocompatibility refers to the ability of a biomaterial to perform its desired function with respect to a medical therapy, without eliciting any undesirable local or systemic effects in the recipient or beneficiary of that therapy, but generating the most appropriate beneficial cellular or tissue re...
Saved in:
| Main Author: | |
|---|---|
| Format: | Electronic Book Chapter |
| Language: | English |
| Published: |
MDPI - Multidisciplinary Digital Publishing Institute
2020
|
| Subjects: | |
| Online Access: | DOAB: download the publication DOAB: description of the publication |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
| LEADER | 00000naaaa2200000uu 4500 | ||
|---|---|---|---|
| 001 | doab_20_500_12854_50582 | ||
| 005 | 20210211 | ||
| 003 | oapen | ||
| 006 | m o d | ||
| 007 | cr|mn|---annan | ||
| 008 | 20210211s2020 xx |||||o ||| 0|eng d | ||
| 020 | |a books978-3-03928-421-4 | ||
| 020 | |a 9783039284214 | ||
| 020 | |a 9783039284207 | ||
| 040 | |a oapen |c oapen | ||
| 024 | 7 | |a 10.3390/books978-3-03928-421-4 |c doi | |
| 041 | 0 | |a eng | |
| 042 | |a dc | ||
| 072 | 7 | |a TBX |2 bicssc | |
| 100 | 1 | |a Kowalczuk, Marek M. |4 auth | |
| 245 | 1 | 0 | |a Intrinsically Biocompatible Polymer Systems |
| 260 | |b MDPI - Multidisciplinary Digital Publishing Institute |c 2020 | ||
| 300 | |a 1 electronic resource (270 p.) | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 506 | 0 | |a Open Access |2 star |f Unrestricted online access | |
| 520 | |a Biocompatibility refers to the ability of a biomaterial to perform its desired function with respect to a medical therapy, without eliciting any undesirable local or systemic effects in the recipient or beneficiary of that therapy, but generating the most appropriate beneficial cellular or tissue response in that specific situation, and optimizing the clinically relevant performance of that therapy, which reflects current developments in the area of intrinsically biocompatible polymer systems. Polymeric biomaterials are presently used as, for example, long-term implantable medical devices, degradable implantable systems, transient invasive intravascular devices, and, recently, as tissue engineering scaffolds. This Special Issue welcomes full papers and short communications highlighting the aspects of the current trends in the area of intrinsically biocompatible polymer systems. | ||
| 540 | |a Creative Commons |f https://creativecommons.org/licenses/by-nc-nd/4.0/ |2 cc |4 https://creativecommons.org/licenses/by-nc-nd/4.0/ | ||
| 546 | |a English | ||
| 650 | 7 | |a History of engineering & technology |2 bicssc | |
| 653 | |a n/a | ||
| 653 | |a hemocompatibility | ||
| 653 | |a tissue engineering | ||
| 653 | |a biocompatible nanoparticles | ||
| 653 | |a enzymatic polymerization | ||
| 653 | |a hyaluronan derivatives | ||
| 653 | |a food-supplement | ||
| 653 | |a X-ray microtomography | ||
| 653 | |a water sorption | ||
| 653 | |a degradation | ||
| 653 | |a drug delivery | ||
| 653 | |a ion-releasing materials | ||
| 653 | |a HepaRG cells | ||
| 653 | |a silk fibroin | ||
| 653 | |a poly(benzyl malate) | ||
| 653 | |a hyaluronan applications | ||
| 653 | |a pluronic F127 | ||
| 653 | |a thermal properties | ||
| 653 | |a cyclohexanone | ||
| 653 | |a solution behavior | ||
| 653 | |a In vitro biosafety | ||
| 653 | |a cosmetic | ||
| 653 | |a osteoblasts | ||
| 653 | |a chemical polymerization | ||
| 653 | |a temporin | ||
| 653 | |a electrospraying | ||
| 653 | |a biodegradability | ||
| 653 | |a cancer diagnosis | ||
| 653 | |a extraction | ||
| 653 | |a contrast agent | ||
| 653 | |a mechanical properties | ||
| 653 | |a biocompatible polymers | ||
| 653 | |a ATRP | ||
| 653 | |a biodegradable nano/microparticles | ||
| 653 | |a hydrolytic degradation | ||
| 653 | |a physicochemical properties | ||
| 653 | |a PEEK copolymer synthesis | ||
| 653 | |a cell uptake | ||
| 653 | |a nanohydroxyapatite | ||
| 653 | |a ionic liquids | ||
| 653 | |a Chitosan | ||
| 653 | |a crosslinking | ||
| 653 | |a bone tunnel enlargement | ||
| 653 | |a porous beads | ||
| 653 | |a drug delivery systems | ||
| 653 | |a biological activity | ||
| 653 | |a PEEK composite | ||
| 653 | |a activation energy of thermal decomposition | ||
| 653 | |a citropin | ||
| 653 | |a MRI | ||
| 653 | |a biodegradable polymers | ||
| 653 | |a chitooligosaccharide | ||
| 653 | |a PHB | ||
| 653 | |a human macrophages | ||
| 653 | |a hyaluronic acid | ||
| 653 | |a scaffolds | ||
| 653 | |a Spine cage application | ||
| 653 | |a physico-chemical properties | ||
| 653 | |a shrinkage stress | ||
| 653 | |a polyurethane | ||
| 653 | |a polyhydroxyalkanoates | ||
| 653 | |a SPION | ||
| 653 | |a cytotoxicity | ||
| 653 | |a septic arthritis | ||
| 653 | |a hydroscopic expansion | ||
| 653 | |a hyaluronan synthases | ||
| 653 | |a ?-butyrolactone | ||
| 653 | |a folate receptor | ||
| 653 | |a molecular weight | ||
| 653 | |a photoelastic investigation | ||
| 653 | |a functionalization | ||
| 653 | |a star polymers | ||
| 653 | |a saliva | ||
| 653 | |a controlled release | ||
| 653 | |a chloroform | ||
| 653 | |a release characteristics | ||
| 653 | |a konjac glucomannan | ||
| 653 | |a microcarriers | ||
| 653 | |a anterior cruciate ligament reconstruction | ||
| 653 | |a hyaluronidases | ||
| 653 | |a biopolymers | ||
| 653 | |a polylactide | ||
| 653 | |a Poly (l-lactic) acid | ||
| 653 | |a antimicrobial peptides | ||
| 856 | 4 | 0 | |a www.oapen.org |u https://mdpi.com/books/pdfview/book/2138 |7 0 |z DOAB: download the publication |
| 856 | 4 | 0 | |a www.oapen.org |u https://directory.doabooks.org/handle/20.500.12854/50582 |7 0 |z DOAB: description of the publication |